QLT Announces Second Quarter Results for 2010

QLT Added to the Russell Global Index

QLT Announces Final Results From Its RADICAL Study Evaluating Verteporfin PDT (Visudyne®) Combination Therapy in Exudative AMD

12-Month Results From DENALI Study Evaluating Verteporfin PDT (Visudyne®) Combination Therapy

2010 Q2 Conference Call

QLT held an investor call to discuss Q2 2010 financial results on Tuesday, July 27 at 8:30 am ET (5:30 am PT). To listen to a replay of the call, click here.

Annual Meeting of Shareholders

QLT’s Annual Meeting of Shareholders was held on Thursday, May 20, 2010. To listen to a replay of Bob Butchofsky’s presentation, with slides, please click here. For slides only, click here.